+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Non-invasive Helicobacter Pylori Diagnostic Market - Global Forecast 2026-2032- Product Image
Non-invasive Helicobacter Pylori Diagnostic Market - Global Forecast 2026-2032- Product Image
New

Non-invasive Helicobacter Pylori Diagnostic Market - Global Forecast 2026-2032

  • Report

  • 194 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6279129
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Non-Invasive Helicobacter pylori Diagnostics: Executive Overview

Non-invasive Helicobacter pylori diagnostics support detection and post-treatment confirmation without endoscopy. The principal modalities are urea breath testing, stool-antigen testing, and serology, with selection shaped by clinical guidelines, access to laboratory infrastructure, patient preference, and the need to distinguish active infection from prior exposure. The field is increasingly focused on accurate first-line diagnosis, appropriate test preparation, antimicrobial stewardship, and reliable confirmation of eradication.

Diagnostic Pathways Are Shifting Toward Accessible, Confirmatory Testing

Clinical practice is moving toward non-invasive testing for appropriate symptomatic patients and groups at elevated risk of peptic-ulcer disease or gastric malignancy. Urea breath and stool-antigen tests are generally suited to identifying active infection and confirming eradication, while serology requires careful interpretation because antibodies may persist after treatment. Greater attention to proton-pump inhibitor, antibiotic, and bismuth washout periods is also improving test validity. At the system level, laboratory centralization, primary-care pathways, simplified sample logistics, and updated antimicrobial-resistance guidance are reshaping how patients are tested and retested.

Artificial Intelligence Strengthens Triage, Interpretation, and Quality Control

Artificial intelligence can contribute across the diagnostic workflow by prioritizing patients for testing, identifying incomplete or inconsistent clinical records, supporting laboratory quality checks, and integrating test results with medication and treatment histories. Natural-language tools may help extract relevant symptoms, prior eradication attempts, and exposure to acid-suppressing medicines from clinical documentation. However, AI does not replace validated assays or clinical judgment: performance depends on representative training data, transparent validation, privacy safeguards, and monitoring for demographic and geographic bias. Its most immediate value is likely to come from workflow efficiency and decision support rather than autonomous diagnosis.

Regional Priorities Differ by Access, Prevalence, and Diagnostic Infrastructure

North America is emphasizing guideline-aligned testing, eradication confirmation, and integration with primary care and gastroenterology workflows. Latin America faces a strong need for affordable testing, reliable specimen transport, and broader access outside major urban centers. Europe is supported by mature laboratory networks but must manage differing national pathways, antimicrobial resistance, and equitable access across health systems. The Middle East is balancing expanding diagnostic capacity with variation in insurance coverage, referral structures, and laboratory availability. Africa requires approaches suited to constrained infrastructure, decentralized care, and supply continuity. Asia-Pacific combines substantial clinical need with wide variation in healthcare resources, making scalable breath-testing, stool-based workflows, and quality-assured laboratory services particularly relevant.

Cross-Group Dynamics Link Policy, Trade, and Health-System Coordination

ASEAN countries are navigating uneven laboratory capacity, cross-border supply chains, and the need for practical primary-care testing models. BRICS members face diverse disease burdens and health-system structures, with opportunities to strengthen local laboratory networks and affordability while maintaining quality standards. The European Union benefits from regulatory and clinical coordination, although implementation remains shaped by national reimbursement and care pathways. G7 systems are generally positioned to emphasize evidence-based testing, resistance-aware treatment, and digital integration. GCC countries are expanding specialized and laboratory services while addressing referral coordination and workforce needs. NATO members may benefit from resilient procurement, interoperability, and preparedness planning for critical diagnostic supplies, without assuming uniform civilian healthcare policies.

Country-Level Readiness Reflects Distinct Clinical and Infrastructure Contexts

Australia and Canada can build on organized healthcare systems by improving primary-care adherence to testing and eradication-confirmation guidance. Brazil, Mexico, India, China, and Russia require approaches that accommodate regional disparities, affordability constraints, and varied laboratory access. France, Germany, Italy, Spain, and the United Kingdom have established clinical and diagnostic infrastructure, but continued attention to guideline implementation, reimbursement, and resistance surveillance remains important. Japan and South Korea have advanced healthcare capabilities and strong opportunities for digitally enabled workflows, quality assurance, and appropriate follow-up. Across all listed countries, reliable medication washout guidance, specimen handling, and clinician education are essential to reducing false results and unnecessary treatment.

Prioritize Validated Workflows, Equitable Access, and Eradication Confirmation

Industry leaders should align assay development and service delivery with current clinical guidelines, clearly communicate medication-interference requirements, and support confirmation of eradication after therapy. They should design distribution and logistics models for both centralized laboratories and decentralized settings, with quality controls that remain practical in resource-constrained environments. Partnerships with clinicians, laboratories, public-health agencies, and patient organizations can improve appropriate test use. Digital tools should be introduced only with clinical validation, cybersecurity protections, explainable outputs, and ongoing performance monitoring. Organizations should also track invalid-test rates, turnaround time, treatment follow-up, and access disparities as operational quality indicators.

Methodology: Evidence Synthesis Across Diagnostics, Guidelines, and Health Systems

This executive summary uses the defined market scope of non-invasive Helicobacter pylori diagnostics and synthesizes established diagnostic modalities, clinical-use principles, healthcare-system considerations, and regional requirements. The assessment distinguishes tests for active infection from methods that may reflect previous exposure, considers factors that can affect result accuracy, and compares implementation needs across the specified regions, groups, and countries. No market estimates, forecasts, market shares, or company-specific claims are used. Conclusions are framed as evidence-based strategic implications rather than quantified commercial projections.

Reliable Non-Invasive Testing Is Central to Better H. pylori Management

The diagnostic landscape is advancing from simple test availability toward integrated, quality-assured pathways that connect initial detection, appropriate treatment, and confirmation of eradication. Regional and country differences make flexible implementation essential, while AI can improve coordination and quality without displacing validated testing or professional judgment. Leaders that focus on accuracy, affordability, resilient supply, responsible digitalization, and guideline adherence will be better positioned to support effective H. pylori management across diverse healthcare environments.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Non-invasive Helicobacter Pylori Diagnostic Market, by Product Type
7.1. Introduction
7.2. Analyzers
7.3. Consumables
7.4. Reagents
7.5. Software And Data Management
7.6. Test Kits
7.6.1. Home Test Kits
7.6.2. Laboratory Kits
7.6.3. Point Of Care Kits
8. Non-invasive Helicobacter Pylori Diagnostic Market, by Test Type
8.1. Introduction
8.2. Molecular Test
8.2.1. Next Generation Sequencing
8.2.2. Nucleic Acid Amplification Test
8.2.3. PCR
8.2.3.1. Conventional PCR
8.2.3.2. Real Time PCR
8.3. Saliva Test
8.4. Serology Test
8.4.1. IgA Antibody Test
8.4.2. IgG Antibody Test
8.4.3. IgM Antibody Test
8.5. Stool Antigen Test
8.5.1. Enzyme Immunoassay Stool Antigen
8.5.2. Molecular Stool PCR
8.5.3. Rapid Stool Antigen Test
8.6. Urea Breath Test
8.6.1. 13C Urea Breath Test
8.6.2. 14C Urea Breath Test
8.7. Urine Test
9. Non-invasive Helicobacter Pylori Diagnostic Market, by Sample Type
9.1. Introduction
9.2. Blood
9.2.1. Plasma
9.2.2. Serum
9.3. Breath
9.4. Saliva
9.5. Stool
9.6. Urine
10. Non-invasive Helicobacter Pylori Diagnostic Market, by Application
10.1. Introduction
10.2. Clinical Research
10.3. Diagnosis
10.4. Epidemiological Surveillance
10.5. Screening
10.5.1. Population Screening
10.5.2. Targeted Screening
10.6. Test Of Cure
11. Non-invasive Helicobacter Pylori Diagnostic Market, by End User
11.1. Introduction
11.2. Clinics
11.2.1. Gastroenterology Clinics
11.2.2. Primary Care Clinics
11.3. Diagnostic Laboratories
11.3.1. Central Labs
11.3.2. Reference Labs
11.4. Home Users
11.5. Hospitals
11.5.1. Community Hospitals
11.5.2. Tertiary Care Hospitals
11.6. Pharmacies
12. Non-invasive Helicobacter Pylori Diagnostic Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Non-invasive Helicobacter Pylori Diagnostic Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Non-invasive Helicobacter Pylori Diagnostic Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Abbott Laboratories
16.2. Bio-Rad Laboratories, Inc.
16.3. Biohit Oyj
16.4. CerTest Biotec S.L.
16.5. Coris BioConcept
16.6. DiaSorin S.p.A.
16.7. Epitope Diagnostics, Inc.
16.8. Exalenz Bioscience Ltd.
16.9. F. Hoffmann-La Roche Ltd.
16.10. Meridian Bioscience, Inc.
16.11. Qiagen N.V.
16.12. Quidel Corporation
16.13. Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd.
16.14. Thermo Fisher Scientific Inc.
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Non-invasive Helicobacter Pylori Diagnostic Market, Years Considered for the Study
FIGURE 2. Global Non-invasive Helicobacter Pylori Diagnostic Market, Research Design
FIGURE 3. Global Non-invasive Helicobacter Pylori Diagnostic Market, Research Framework
FIGURE 4. Global Non-invasive Helicobacter Pylori Diagnostic Market, Data Triangulation
FIGURE 5. Global Non-invasive Helicobacter Pylori Diagnostic Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Non-invasive Helicobacter Pylori Diagnostic Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Non-invasive Helicobacter Pylori Diagnostic Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Non-invasive Helicobacter Pylori Diagnostic Market Size, by Test Type, 2025 vs 2032 (%)
FIGURE 9. Global Non-invasive Helicobacter Pylori Diagnostic Market Size, by Test Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Non-invasive Helicobacter Pylori Diagnostic Market Size, by Sample Type, 2025 vs 2032 (%)
FIGURE 11. Global Non-invasive Helicobacter Pylori Diagnostic Market Size, by Sample Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Non-invasive Helicobacter Pylori Diagnostic Market Size, by Application, 2025 vs 2032 (%)
FIGURE 13. Global Non-invasive Helicobacter Pylori Diagnostic Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Non-invasive Helicobacter Pylori Diagnostic Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Non-invasive Helicobacter Pylori Diagnostic Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Non-invasive Helicobacter Pylori Diagnostic Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Non-invasive Helicobacter Pylori Diagnostic Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Non-invasive Helicobacter Pylori Diagnostic Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Non-invasive Helicobacter Pylori Diagnostic Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Non-invasive Helicobacter Pylori Diagnostic Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Non-invasive Helicobacter Pylori Diagnostic Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Non-invasive Helicobacter Pylori Diagnostic Market Segmentation & Coverage
TABLE 2. Global Non-invasive Helicobacter Pylori Diagnostic Market Size, 2017-2032 (USD Million)
TABLE 3. Global Non-invasive Helicobacter Pylori Diagnostic Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Analyzers Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Analyzers Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Analyzers Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Consumables Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Consumables Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Consumables Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Software And Data Management Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Software And Data Management Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Software And Data Management Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Test Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Test Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Test Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Home Test Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Home Test Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Home Test Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Laboratory Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Laboratory Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Laboratory Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Point Of Care Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Point Of Care Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Point Of Care Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Non-invasive Helicobacter Pylori Diagnostic Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 29. Global Molecular Test Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Molecular Test Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Molecular Test Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Next Generation Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Next Generation Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Next Generation Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Nucleic Acid Amplification Test Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Nucleic Acid Amplification Test Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Nucleic Acid Amplification Test Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global PCR Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global PCR Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global PCR Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Conventional PCR Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Conventional PCR Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Conventional PCR Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Real Time PCR Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Real Time PCR Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Real Time PCR Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Saliva Test Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Saliva Test Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Saliva Test Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Serology Test Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Serology Test Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Serology Test Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global IgA Antibody Test Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global IgA Antibody Test Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global IgA Antibody Test Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global IgG Antibody Test Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global IgG Antibody Test Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global IgG Antibody Test Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global IgM Antibody Test Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global IgM Antibody Test Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global IgM Antibody Test Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Stool Antigen Test Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Stool Antigen Test Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Stool Antigen Test Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Enzyme Immunoassay Stool Antigen Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Enzyme Immunoassay Stool Antigen Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Enzyme Immunoassay Stool Antigen Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Molecular Stool PCR Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Molecular Stool PCR Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Molecular Stool PCR Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Rapid Stool Antigen Test Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Rapid Stool Antigen Test Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Rapid Stool Antigen Test Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global Urea Breath Test Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Global Urea Breath Test Market Size, by Group, 2017-2032 (USD Million)
TABLE 76. Global Urea Breath Test Market Size, by Country, 2017-2032 (USD Million)
TABLE 77. Global 13C Urea Breath Test Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Global 13C Urea Breath Test Market Size, by Group, 2017-2032 (USD Million)
TABLE 79. Global 13C Urea Breath Test Market Size, by Country, 2017-2032 (USD Million)
TABLE 80. Global 14C Urea Breath Test Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Global 14C Urea Breath Test Market Size, by Group, 2017-2032 (USD Million)
TABLE 82. Global 14C Urea Breath Test Market Size, by Country, 2017-2032 (USD Million)
TABLE 83. Global Urine Test Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Global Urine Test Market Size, by Group, 2017-2032 (USD Million)
TABLE 85. Global Urine Test Market Size, by Country, 2017-2032 (USD Million)
TABLE 86. Global Non-invasive Helicobacter Pylori Diagnostic Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 87. Global Blood Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Global Blood Market Size, by Group, 2017-2032 (USD Million)
TABLE 89. Global Blood Market Size, by Country, 2017-2032 (USD Million)
TABLE 90. Global Plasma Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Global Plasma Market Size, by Group, 2017-2032 (USD Million)
TABLE 92. Global Plasma Market Size, by Country, 2017-2032 (USD Million)
TABLE 93. Global Serum Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. Global Serum Market Size, by Group, 2017-2032 (USD Million)
TABLE 95. Global Serum Market Size, by Country, 2017-2032 (USD Million)
TABLE 96. Global Breath Market Size, by Region, 2017-2032 (USD Million)
TABLE 97. Global Breath Market Size, by Group, 2017-2032 (USD Million)
TABLE 98. Global Breath Market Size, by Country, 2017-2032 (USD Million)
TABLE 99. Global Saliva Market Size, by Region, 2017-2032 (USD Million)
TABLE 100. Global Saliva Market Size, by Group, 2017-2032 (USD Million)
TABLE 101. Global Saliva Market Size, by Country, 2017-2032 (USD Million)
TABLE 102. Global Stool Market Size, by Region, 2017-2032 (USD Million)
TABLE 103. Global Stool Market Size, by Group, 2017-2032 (USD Million)
TABLE 104. Global Stool Market Size, by Country, 2017-2032 (USD Million)
TABLE 105. Global Urine Market Size, by Region, 2017-2032 (USD Million)
TABLE 106. Global Urine Market Size, by Group, 2017-2032 (USD Million)
TABLE 107. Global Urine Market Size, by Country, 2017-2032 (USD Million)
TABLE 108. Global Non-invasive Helicobacter Pylori Diagnostic Market Size, by Application, 2017-2032 (USD Million)
TABLE 109. Global Clinical Research Market Size, by Region, 2017-2032 (USD Million)
TABLE 110. Global Clinical Research Market Size, by Group, 2017-2032 (USD Million)
TABLE 111. Global Clinical Research Market Size, by Country, 2017-2032 (USD Million)
TABLE 112. Global Diagnosis Market Size, by Region, 2017-2032 (USD Million)
TABLE 113. Global Diagnosis Market Size, by Group, 2017-2032 (USD Million)
TABLE 114. Global Diagnosis Market Size, by Country, 2017-2032 (USD Million)
TABLE 115. Global Epidemiological Surveillance Market Size, by Region, 2017-2032 (USD Million)
TABLE 116. Global Epidemiological Surveillance Market Size, by Group, 2017-2032 (USD Million)
TABLE 117. Global Epidemiological Surveillance Market Size, by Country, 2017-2032 (USD Million)
TABLE 118. Global Screening Market Size, by Region, 2017-2032 (USD Million)
TABLE 119. Global Screening Market Size, by Group, 2017-2032 (USD Million)
TABLE 120. Global Screening Market Size, by Country, 2017-2032 (USD Million)
TABLE 121. Global Population Screening Market Size, by Region, 2017-2032 (USD Million)
TABLE 122. Global Population Screening Market Size, by Group, 2017-2032 (USD Million)
TABLE 123. Global Population Screening Market Size, by Country, 2017-2032 (USD Million)
TABLE 124. Global Targeted Screening Market Size, by Region, 2017-2032 (USD Million)
TABLE 125. Global Targeted Screening Market Size, by Group, 2017-2032 (USD Million)
TABLE 126. Global Targeted Screening Market Size, by Country, 2017-2032 (USD Million)
TABLE 127. Global Test Of Cure Market Size, by Region, 2017-2032 (USD Million)
TABLE 128. Global Test Of Cure Market Size, by Group, 2017-2032 (USD Million)
TABLE 129. Global Test Of Cure Market Size, by Country, 2017-2032 (USD Million)
TABLE 130. Global Non-invasive Helicobacter Pylori Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 131. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 132. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 133. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 134. Global Gastroenterology Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 135. Global Gastroenterology Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 136. Global Gastroenterology Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 137. Global Primary Care Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 138. Global Primary Care Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 139. Global Primary Care Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 140. Global Diagnostic Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 141. Global Diagnostic Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 142. Global Diagnostic Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 143. Global Central Labs Market Size, by Region, 2017-2032 (USD Million)
TABLE 144. Global Central Labs Market Size, by Group, 2017-2032 (USD Million)
TABLE 145. Global Central Labs Market Size, by Country, 2017-2032 (USD Million)
TABLE 146. Global Reference Labs Market Size, by Region, 2017-2032 (USD Million)
TABLE 147. Global Reference Labs Market Size, by Group, 2017-2032 (USD Million)
TABLE 148. Global Reference Labs Market Size, by Country, 2017-2032 (USD Million)
TABLE 149. Global Home Users Market Size, by Region, 2017-2032 (USD Million)
TABLE 150. Global Home Users Market Size, by Group, 2017-2032 (USD Million)
TABLE 151. Global Home Users Market Size, by Country, 2017-2032 (USD Million)
TABLE 152. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 153. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 154. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 155. Global Community Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 156. Global Community Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 157. Global Community Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 158. Global Tertiary Care Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 159. Global Tertiary Care Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 160. Global Tertiary Care Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 161. Global Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 162. Global Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 163. Global Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 164. Global Non-invasive Helicobacter Pylori Diagnostic Market Size, by Region, 2017-2032 (USD Million)
TABLE 165. Asia-Pacific Non-invasive Helicobacter Pylori Diagnostic Market Size, by Region, 2017-2032 (USD Million)
TABLE 166. Asia-Pacific Non-invasive Helicobacter Pylori Diagnostic Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 167. Asia-Pacific Non-invasive Helicobacter Pylori Diagnostic Market Size, by Test Kits, 2017-2032 (USD Million)
TABLE 168. Asia-Pacific Non-invasive Helicobacter Pylori Diagnostic Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 169. Asia-Pacific Non-invasive Helicobacter Pylori Diagnostic Market Size, by Molecular Test, 2017-2032 (USD Million)
TABLE 170. Asia-Pacific Non-invasive Helicobacter Pylori Diagnostic Market Size, by PCR, 2017-2032 (USD Million)
TABLE 171. Asia-Pacific Non-invasive Helicobacter Pylori Diagnostic Market Size, by Serology Test, 2017-2032 (USD Million)
TABLE 172. Asia-Pacific Non-invasive Helicobacter Pylori Diagnostic Market Size, by Stool Antigen Test, 2017-2032 (USD Million)
TABLE 173. Asia-Pacific Non-invasive Helicobacter Pylori Diagnostic Market Size, by Urea Breath Test, 2017-2032 (USD Million)
TABLE 174. Asia-Pacific Non-invasive Helicobacter Pylori Diagnostic Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 175. Asia-Pacific Non-invasive Helicobacter Pylori Diagnostic Market Size, by Blood, 2017-2032 (USD Million)
TABLE 176. Asia-Pacific Non-invasive Helicobacter Pylori Diagnostic Market Size, by Application, 2017-2032 (USD Million)
TABLE 177. Asia-Pacific Non-invasive Helicobacter Pylori Diagnostic Market Size, by Screening, 2017-2032 (USD Million)
TABLE 178. Asia-Pacific Non-invasive Helicobacter Pylori Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 179. Asia-Pacific Non-invasive Helicobacter Pylori Diagnostic Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 180. Asia-Pacific Non-invasive Helicobacter Pylori Diagnostic Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 181. Asia-Pacific Non-invasive Helicobacter Pylori Diagnostic Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 182. North America Non-invasive Helicobacter Pylori Diagnostic Market Size, by Region, 2017-2032 (USD Million)
TABLE 183. North America Non-invasive Helicobacter Pylori Diagnostic Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 184. North America Non-invasive Helicobacter Pylori Diagnostic Market Size, by Test Kits, 2017-2032 (USD Million)
TABLE 185. North America Non-invasive Helicobacter Pylori Diagnostic Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 186. North America Non-invasive Helicobacter Pylori Diagnostic Market Size, by Molecular Test, 2017-2032 (USD Million)
TABLE 187. North America Non-invasive Helicobacter Pylori Diagnostic Market Size, by PCR, 2017-2032 (USD Million)
TABLE 188. North America Non-invasive Helicobacter Pylori Diagnostic Market Size, by Serology Test, 2017-2032 (USD Million)
TABLE 189. North America Non-invasive Helicobacter Pylori Diagnostic Market Size, by Stool Antigen Test, 2017-2032 (USD Million)
TABLE 190. North America Non-invasive Helicobacter Pylori Diagnostic Market Size, by Urea Breath Test, 2017-2032 (USD Million)
TABLE 191. North America Non-invasive Helicobacter Pylori Diagnostic Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 192. North America Non-invasive Helicobacter Pylori Diagnostic Market Size, by Blood, 2017-2032 (USD Million)
TABLE 193. North America Non-invasive Helicobacter Pylori Diagnostic Market Size, by Application, 2017-2032 (USD Million)
TABLE 194. North America Non-invasive Helicobacter Pylori Diagnostic Market Size, by Screening, 2017-2032 (USD Million)
TABLE 195. North America Non-invasive Helicobacter Pylori Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 196. North America Non-invasive Helicobacter Pylori Diagnostic Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 197. North America Non-invasive Helicobacter Pylori Diagnostic Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 198. North America Non-invasive Helicobacter Pylori Diagnostic Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 199. Latin America Non-invasive Helicobacter Pylori Diagnostic Market Size, by Region, 2017-2032 (USD Million)
TABLE 200. Latin America Non-invasive Helicobacter Pylori Diagnostic Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 201. Latin America Non-invasive Helicobacter Pylori Diagnostic Market Size, by Test Kits, 2017-2032 (USD Million)
TABLE 202. Latin America Non-invasive Helicobacter Pylori Diagnostic Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 203. Latin America Non-invasive Helicobacter Pylori Diagnostic Market Size, by Molecular Test, 2017-2032 (USD Million)
TABLE 204. Latin America Non-invasive Helicobacter Pylori Diagnostic Market Size, by PCR, 2017-2032 (USD Million)
TABLE 205. Latin America Non-invasive Helicobacter Pylori Diagnostic Market Size, by Serology Test, 2017-2032 (USD Million)
TABLE 206. Latin America Non-invasive Helicobacter Pylori Diagnostic Market Size, by Stool Antigen Test, 2017-2032 (USD Million)
TABLE 207. Latin America Non-invasive Helicobacter Pylori Diagnostic Market Size, by Urea Breath Test, 2017-2032 (USD Million)
TABLE 208. Latin America Non-invasive Helicobacter Pylori Diagnostic Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 209. Latin America Non-invasive Helicobacter Pylori Diagnostic Market Size, by Blood, 2017-2032 (USD Million)
TABLE 210. Latin America Non-invasive Helicobacter Pylori Diagnostic Market Size, by Application, 2017-2032 (USD Million)
TABLE 211. Latin America Non-invasive Helicobacter Pylori Diagnostic Market Size, by Screening, 2017-2032 (USD Million)
TABLE 212. Latin America Non-invasive Helicobacter Pylori Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 213. Latin America Non-invasive Helicobacter Pylori Diagnostic Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 214. Latin America Non-invasive Helicobacter Pylori Diagnostic Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 215. Latin America Non-invasive Helicobacter Pylori Diagnostic Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 216. Europe Non-invasive Helicobacter Pylori Diagnostic Market Size, by Region, 2017-2032 (USD Million)
TABLE 217. Europe Non-invasive Helicobacter Pylori Diagnostic Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 218. Europe Non-invasive Helicobacter Pylori Diagnostic Market Size, by Test Kits, 2017-2032 (USD Million)
TABLE 219. Europe Non-invasive Helicobacter Pylori Diagnostic Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 220. Europe Non-invasive Helicobacter Pylori Diagnostic Market Size, by Molecular Test, 2017-2032 (USD Million)
TABLE 221. Europe Non-invasive Helicobacter Pylori Diagnostic Market Size, by PCR, 2017-2032 (USD Million)
TABLE 222. Europe Non-invasive Helicobacter Pylori Diagnostic Market Size, by Serology Test, 2017-2032 (USD Million)
TABLE 223. Europe Non-invasive Helicobacter Pylori Diagnostic Market Size, by Stool Antigen Test, 2017-2032 (USD Million)
TABLE 224. Europe Non-invasive Helicobacter Pylori Diagnostic Market Size, by Urea Breath Test, 2017-2032 (USD Million)
TABLE 225. Europe Non-invasive Helicobacter Pylori Diagnostic Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 226. Europe Non-invasive Helicobacter Pylori Diagnostic Market Size, by Blood, 2017-2032 (USD Million)
TABLE 227. Europe Non-invasive Helicobacter Pylori Diagnostic Market Size, by Application, 2017-2032 (USD Million)
TABLE 228. Europe Non-invasive Helicobacter Pylori Diagnostic Market Size, by Screening, 2017-2032 (USD Million)
TABLE 229. Europe Non-invasive Helicobacter Pylori Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 230. Europe Non-invasive Helicobacter Pylori Diagnostic Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 231. Europe Non-invasive Helicobacter Pylori Diagnostic Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 232. Europe Non-invasive Helicobacter Pylori Diagnostic Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 233. Middle East Non-invasive Helicobacter Pylori Diagnostic Market Size, by Region, 2017-2032 (USD Million)
TABLE 234. Middle East Non-invasive Helicobacter Pylori Diagnostic Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 235. Middle East Non-invasive Helicobacter Pylori Diagnostic Market Size, by Test Kits, 2017-2032 (USD Million)
TABLE 236. Middle East Non-invasive Helicobacter Pylori Diagnostic Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 237. Middle East Non-invasive Helicobacter Pylori Diagnostic Market Size, by Molecular Test, 2017-2032 (USD Million)
TABLE 238. Middle East Non-invasive Helicobacter Pylori Diagnostic Market Size, by PCR, 2017-2032 (USD Million)
TABLE 239. Middle East Non-invasive Helicobacter Pylori Diagnostic Market Size, by Serology Test, 2017-2032 (USD Million)
TABLE 240. Middle East Non-invasive Helicobacter Pylori Diagnostic Market Size, by Stool Antigen Test, 2017-2032 (USD Million)
TABLE 241. Middle East Non-invasive Helicobacter Pylori Diagnostic Market Size, by Urea Breath Test, 2017-2032 (USD Million)
TABLE 242. Middle East Non-invasive Helicobacter Pylori Diagnostic Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 243. Middle East Non-invasive Helicobacter Pylori Diagnostic Market Size, by Blood, 2017-2032 (USD Million)
TABLE 244. Middle East Non-invasive Helicobacter Pylori Diagnostic Market Size, by Application, 2017-2032 (USD Million)
TABLE 245. Middle East Non-invasive Helicobacter Pylori Diagnostic Market Size, by Screening, 2017-2032 (USD Million)
TABLE 246. Middle East Non-invasive Helicobacter Pylori Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 247. Middle East Non-invasive Helicobacter Pylori Diagnostic Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 248. Middle East Non-invasive Helicobacter Pylori Diagnostic Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 249. Middle East Non-invasive Helicobacter Pylori Diagnostic Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 250. Africa Non-invasive Helicobacter Pylori Diagnostic Market Size, by Region, 2017-2032 (USD Million)
TABLE 251. Africa Non-invasive Helicobacter Pylori Diagnostic Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 252. Africa Non-invasive Helicobacter Pylori Diagnostic Market Size, by Test Kits, 2017-2032 (USD Million)
TABLE 253. Africa Non-invasive Helicobacter Pylori Diagnostic Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 254. Africa Non-invasive Helicobacter Pylori Diagnostic Market Size, by Molecular Test, 2017-2032 (USD Million)
TABLE 255. Africa Non-invasive Helicobacter Pylori Diagnostic Market Size, by PCR, 2017-2032 (USD Million)
TABLE 256. Africa Non-invasive Helicobacter Pylori Diagnostic Market Size, by Serology Test, 2017-2032 (USD Million)
TABLE 257. Africa Non-invasive Helicobacter Pylori Diagnostic Market Size, by Stool Antigen Test, 2017-2032 (USD Million)
TABLE 258. Africa Non-invasive Helicobacter Pylori Diagnostic Market Size, by Urea Breath Test, 2017-2032 (USD Million)
TABLE 259. Africa Non-invasive Helicobacter Pylori Diagnostic Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 260. Africa Non-invasive Helicobacter Pylori Diagnostic Market Size, by Blood, 2017-2032 (USD Million)
TABLE 261. Africa Non-invasive Helicobacter Pylori Diagnostic Market Size, by Application, 2017-2032 (USD Million)
TABLE 262. Africa Non-invasive Helicobacter Pylori Diagnostic Market Size, by Screening, 2017-2032 (USD Million)
TABLE 263. Africa Non-invasive Helicobacter Pylori Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 264. Africa Non-invasive Helicobacter Pylori Diagnostic Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 265. Africa Non-invasive Helicobacter Pylori Diagnostic Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 266. Africa Non-invasive Helicobacter Pylori Diagnostic Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 267. Global Non-invasive Helicobacter Pylori Diagnostic Market Size, by Group, 2017-2032 (USD Million)
TABLE 268. ASEAN Non-invasive Helicobacter Pylori Diagnostic Market Size, by Group, 2017-2032 (USD Million)
TABLE 269. ASEAN Non-invasive Helicobacter Pylori Diagnostic Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 270. ASEAN Non-invasive Helicobacter Pylori Diagnostic Market Size, by Test Kits, 2017-2032 (USD Million)
TABLE 271. ASEAN Non-invasive Helicobacter Pylori Diagnostic Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 272. ASEAN Non-invasive Helicobacter Pylori Diagnostic Market Size, by Molecular Test, 2017-2032 (USD Million)
TABLE 273. ASEAN Non-invasive Helicobacter Pylori Diagnostic Market Size, by PCR, 2017-2032 (USD Million)
TABLE 274. ASEAN Non-invasive Helicobacter Pylori Diagnostic Market Size, by Serology Test, 2017-2032 (USD Million)
TABLE 275. ASEAN Non-invasive Helicobacter Pylori Diagnostic Market Size, by Stool Antigen Test, 2017-2032 (USD Million)
TABLE 276. ASEAN Non-invasive Helicobacter Pylori Diagnostic Market Size, by Urea Breath Test, 2017-2032 (USD Million)
TABLE 277. ASEAN Non-invasive Helicobacter Pylori Diagnostic Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 278. ASEAN Non-invasive Helicobacter Pylori Diagnostic Market Size, by Blood, 2017-2032 (USD Million)
TABLE 279. ASEAN Non-invasive Helicobacter Pylori Diagnostic Market Size, by Application, 2017-2032 (USD Million)
TABLE 280. ASEAN Non-invasive Helicobacter Pylori Diagnostic Market Size, by Screening, 2017-2032 (USD Million)
TABLE 281. ASEAN Non-invasive Helicobacter Pylori Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 282. ASEAN Non-invasive Helicobacter Pylori Diagnostic Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 283. ASEAN Non-invasive Helicobacter Pylori Diagnostic Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 284. ASEAN Non-invasive Helicobacter Pylori Diagnostic Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 285. GCC Non-invasive Helicobacter Pylori Diagnostic Market Size, by Group, 2017-2032 (USD Million)
TABLE 286. GCC Non-invasive Helicobacter Pylori Diagnostic Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 287. GCC Non-invasive Helicobacter Pylori Diagnostic Market Size, by Test Kits, 2017-2032 (USD Million)
TABLE 288. GCC Non-invasive Helicobacter Pylori Diagnostic Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 289. GCC Non-invasive Helicobacter Pylori Diagnostic Market Size, by Molecular Test, 2017-2032 (USD Million)
TABLE 290. GCC Non-invasive Helicobacter Pylori Diagnostic Market Size, by PCR, 2017-2032 (USD Million)
TABLE 291. GCC Non-invasive Helicobacter Pylori Diagnostic Market Size, by Serology Test, 2017-2032 (USD Million)
TABLE 292. GCC Non-invasive Helicobacter Pylori Diagnostic Market Size, by Stool Antigen Test, 2017-2032 (USD Million)
TABLE 293. GCC Non-invasive Helicobacter Pylori Diagnostic Market Size, by Urea Breath Test, 2017-2032 (USD Million)
TABLE 294. GCC Non-invasive Helicobacter Pylori Diagnostic Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 295. GCC Non-invasive Helicobacter Pylori Diagnostic Market Size, by Blood, 2017-2032 (USD Million)
TABLE 296. GCC Non-invasive Helicobacter Pylori Diagnostic Market Size, by Application, 2017-2032 (USD Million)
TABLE 297. GCC Non-invasive Helicobacter Pylori Diagnostic Market Size, by Screening, 2017-2032 (USD Million)
TABLE 298. GCC Non-invasive Helicobacter Pylori Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 299. GCC Non-invasive Helicobacter Pylori Diagnostic Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 300. GCC Non-invasive Helicobacter Pylori Diagnostic Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 301. GCC Non-invasive Helicobacter Pylori Diagnostic Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 302. European Union Non-invasive Helicobacter Pylori Diagnostic Market Size, by Group, 2017-2032 (USD Million)
TABLE 303. European Union Non-invasive Helicobacter Pylori Diagnostic Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 304. European Union Non-invasive Helicobacter Pylori Diagnostic Market Size, by Test Kits, 2017-2032 (USD Million)
TABLE 305. European Union Non-invasive Helicobacter Pylori Diagnostic Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 306. European Union Non-invasive Helicobacter Pylori Diagnostic Market Size, by Molecular Test, 2017-2032 (USD Million)
TABLE 307. European Union Non-invasive Helicobacter Pylori Diagnostic Market Size, by PCR, 2017-2032 (USD Million)
TABLE 308. European Union Non-invasive Helicobacter Pylori Diagnostic Market Size, by Serology Test, 2017-2032 (USD Million)
TABLE 309. European Union Non-invasive Helicobacter Pylori Diagnostic Market Size, by Stool Antigen Test, 2017-2032 (USD Million)
TABLE 310. European Union Non-invasive Helicobacter Pylori Diagnostic Market Size, by Urea Breath Test, 2017-2032 (USD Million)
TABLE 311. European Union Non-invasive Helicobacter Pylori Diagnostic Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 312. European Union Non-invasive Helicobacter Pylori Diagnostic Market Size, by Blood, 2017-2032 (USD Million)
TABLE 313. European Union Non-invasive Helicobacter Pylori Diagnostic Market Size, by Application, 2017-2032 (USD Million)
TABLE 314. European Union Non-invasive Helicobacter Pylori Diagnostic Market Size, by Screening, 2017-2032 (USD Million)
TABLE 315. European Union Non-invasive Helicobacter Pylori Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 316. European Union Non-invasive Helicobacter Pylori Diagnostic Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 317. European Union Non-invasive Helicobacter Pylori Diagnostic Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 318. European Union Non-invasive Helicobacter Pylori Diagnostic Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 319. BRICS Non-invasive Helicobacter Pylori Diagnostic Market Size, by Group, 2017-2032 (USD Million)
TABLE 320. BRICS Non-invasive Helicobacter Pylori Diagnostic Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 321. BRICS Non-invasive Helicobacter Pylori Diagnostic Market Size, by Test Kits, 2017-2032 (USD Million)
TABLE 322. BRICS Non-invasive Helicobacter Pylori Diagnostic Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 323. BRICS Non-invasive Helicobacter Pylori Diagnostic Market Size, by Molecular Test, 2017-2032 (USD Million)
TABLE 324. BRICS Non-invasive Helicobacter Pylori Diagnostic Market Size, by PCR, 2017-2032 (USD Million)
TABLE 325. BRICS Non-invasive Helicobacter Pylori Diagnostic Market Size, by Serology Test, 2017-2032 (USD Million)
TABLE 326. BRICS Non-invasive Helicobacter Pylori Diagnostic Market Size, by Stool Antigen Test, 2017-2032 (USD Million)
TABLE 327. BRICS Non-invasive Helicobacter Pylori Diagnostic Market Size, by Urea Breath Test, 2017-2032 (USD Million)
TABLE 328. BRICS Non-invasive Helicobacter Pylori D

Companies Mentioned

  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • Biohit Oyj
  • CerTest Biotec S.L.
  • Coris BioConcept
  • DiaSorin S.p.A.
  • Epitope Diagnostics, Inc.
  • Exalenz Bioscience Ltd.
  • F. Hoffmann-La Roche Ltd.
  • Meridian Bioscience, Inc.
  • Qiagen N.V.
  • Quidel Corporation
  • Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd.
  • Thermo Fisher Scientific Inc.

Related Topics

Related Reports

Helicobacter Pylori Non-invasive Testing Market - Global Forecast 2026-2032 - Product Image

Helicobacter Pylori Non-invasive Testing Market - Global Forecast 2026-2032

  • Report
  • 196 Pages
  • Global
From
Helicobacter Pylori Diagnostics Market - Global Forecast 2026-2032 - Product Image

Helicobacter Pylori Diagnostics Market - Global Forecast 2026-2032

  • Report
  • 197 Pages
  • Global
From
Helicobacter Pylori Testing Market - Global Forecast 2026-2032 - Product Image

Helicobacter Pylori Testing Market - Global Forecast 2026-2032

  • Report
  • 189 Pages
  • Global
From
Gastric Helicobacter Pylori Detection Kits Market - Global Forecast 2026-2032 - Product Image

Gastric Helicobacter Pylori Detection Kits Market - Global Forecast 2026-2032

  • Report
  • 185 Pages
  • Global
From
Non-invasive Helicobacter Pylori Breath Tester Market - Global Forecast 2026-2032 - Product Image

Non-invasive Helicobacter Pylori Breath Tester Market - Global Forecast 2026-2032

  • Report
  • 182 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.